Pegapamodutide
Pegapamodutide (LY-2944876) is a dual glucagon and GLP-1 receptor agonist used in metabolic disease research. It is applied in studies investigating mechanisms for glucose control and weight loss, with utility in both in vitro receptor activation assays and in vivo models of type 2 diabetes and obesity.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
288864-01 50 mg
(1R,4S) -rel-4- (acetylamino) -2-cyclopentene-1-carboxylic acid methyl ester
Sign In for Pricing
View Details 288864-02 100 mg
(1R,4S) -rel-4- (acetylamino) -2-cyclopentene-1-carboxylic acid methyl ester
Sign In for Pricing
View Details 288864-03 250 mg
(1R,4S) -rel-4- (acetylamino) -2-cyclopentene-1-carboxylic acid methyl ester
Sign In for Pricing
View Details 288864-04 500 mg
(1R,4S) -rel-4- (acetylamino) -2-cyclopentene-1-carboxylic acid methyl ester
Sign In for Pricing
View Details 288864-05 1 g
(1R,4S) -rel-4- (acetylamino) -2-cyclopentene-1-carboxylic acid methyl ester
Sign In for Pricing
View Details 